Cargando…

Treatment of osteoporotic fractures in alkaptonuria by teriparatide stimulates bone formation and decreases fracture rate – A report of two cases

Two cases of advanced alkaptonuria (AKU) with co-existing osteoporosis are described. Case 1 developed multiple non-vertebral fragility fractures, while Case 2 developed vertebral fragility fractures, both refractory to bisphosphonates. Difficulties in diagnosing osteoporosis in AKU complicated by e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ranganath, L.R., Khedr, M., Mistry, A., Vinjamuri, S., Gallagher, J.A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Full Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649650/ https://www.ncbi.nlm.nih.gov/pubmed/34926730 http://dx.doi.org/10.1016/j.bonr.2021.101151

Ejemplares similares

Metabolomic studies in the inborn error of metabolism alkaptonuria reveal new biotransformations in tyrosine metabolism
por: Norman, Brendan P., et al.
Publicado: (2021)

Data on items of AKUSSI in Alkaptonuria collected over three years from the United Kingdom National Alkaptonuria Centre and the impact of nitisinone
por: Griffin, R., et al.
Publicado: (2018)

First decade anniversary of the United Kingdom National Alkaptonuria Centre
por: Khedr, Milad, et al.
Publicado: (2023)

Usefulness of cortical thickness ratio of the third metacarpal bone for prediction of major osteoporotic fractures
por: Yoshii, Ichiro, et al.
Publicado: (2021)

Teriparatide Improves Fracture Healing and Early Functional Recovery in Treatment of Osteoporotic Intertrochanteric Fractures
por: Huang, Tsan-Wen, et al.
Publicado: (2016)

Increased prevalence of Parkinson's disease in alkaptonuria
por: Ranganath, Lakshminarayan, et al.
Publicado: (2023)

Reversal of ochronotic pigmentation in alkaptonuria following nitisinone therapy: Analysis of data from the United Kingdom National Alkaptonuria Centre
por: Ranganath, Lakshminarayan R., et al.
Publicado: (2020)

Nonsurgical Corrective Union of Osteoporotic Vertebral Fracture with Once-Weekly Teriparatide
por: Miyakoshi, Naohisa, et al.
Publicado: (2015)

Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuria
por: Ranganath, L.R., et al.
Publicado: (2022)

Effects of teriparatide on cementless bipolar hemiarthroplasty in patients with osteoporotic femoral neck fractures
por: Huang, Tsan-Wen, et al.
Publicado: (2016)

Therapeutic Effect of Teriparatide for Osteoporotic Thoracolumbar Burst Fracture in Elderly Female Patients
por: Yu, Dongwoo, et al.
Publicado: (2020)

Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria
por: Ranganath, L. R., et al.
Publicado: (2022)

Kyphoplasty versus vertebroplasty for painful osteoporotic vertebral compression fractures—which one is better? A systematic review and meta-analysis
por: Yang, Huilin, et al.
Publicado: (2013)

Development of an Effective Therapy for Alkaptonuria – Lessons for Osteoarthritis
por: Gallagher, James A., et al.
Publicado: (2021)

Effect of Teriparatide on Subsequent Vertebral Fractures after Instrumented Fusion Surgery for Osteoporotic Vertebral Fractures with Neurological Deficits
por: Maruo, Keishi, et al.
Publicado: (2019)

Analysis of radiologic and clinical outcome in acute osteoporotic vertebral compression fracture: Single-agent teriparatide vs. teriparatide with subsequent vertebroplasty()
por: Jin, Yongjun
Publicado: (2023)

Current Role and Application of Teriparatide in Fracture Healing of Osteoporotic Patients: A Systematic Review
por: Kim, Sang-Min, et al.
Publicado: (2017)

Association of alkaptonuria and low dose nitisinone therapy with cataract formation in a large cohort of patients
por: Ahmad, Mohammad S. Z., et al.
Publicado: (2022)

Quantification of the flux of tyrosine pathway metabolites during nitisinone treatment of Alkaptonuria
por: Milan, A. M., et al.
Publicado: (2019)

Vitiligo, alkaptonuria, and nitisinone—A report of three families and review of the literature
por: Ranganath, Lakshminarayan, et al.
Publicado: (2021)

Dilemmas in the diagnosis and management of osteoporosis in a patient with alkaptonuria: Successful treatment with teriparatide
por: Ebrahim, Ismail C., et al.
Publicado: (2022)

Alkaptonuria: Current Perspectives
por: Zatkova, Andrea, et al.
Publicado: (2020)

Teriparatide in Fracture Non-Unions
por: Coppola, C., et al.
Publicado: (2014)

Effects of teriparatide on lung function and pain relief in women with multiple osteoporotic vertebral compression fractures
por: Chen, Chien-Min, et al.
Publicado: (2014)

The Effect of Teriparatide on Fracture Healing of Osteoporotic Patients: A Meta-Analysis of Randomized Controlled Trials
por: Lou, Shenghan, et al.
Publicado: (2016)

Can Three Months of Teriparatide Be One of Treatment Options for Osteoporotic Vertebral Compression Fracture Patients?
por: Kang, Jung Hoon, et al.
Publicado: (2019)

The Application of Vertebral Augmentation Procedures and Teriparatide in the Treatment of Osteoporotic Vertebral Compression Fractures [Response to Letter]
por: Kong, Meng, et al.
Publicado: (2020)

Five-year risk of fracture and subsequent fractures among adults with cerebral palsy
por: Whitney, Daniel G., et al.
Publicado: (2022)

Fatal acute haemolysis and methaemoglobinaemia in a man with renal failure and Alkaptonuria – Is nitisinone the solution?
por: Davison, A.S., et al.
Publicado: (2020)

Efficacy of teriparatide compared with risedronate on FRAX(®)-defined major osteoporotic fractures: results of the VERO clinical trial
por: Body, J.-J., et al.
Publicado: (2020)

A case report of pregnancy in untreated alkaptonuria – Focus on urinary tissue remodelling markers
por: Ranganath, L.R., et al.
Publicado: (2021)

Effects of Weekly Teriparatide Administration for Vertebral Stability and Bony Union in Patients with Acute Osteoporotic Vertebral Fractures
por: Kitaguchi, Kazuma, et al.
Publicado: (2019)

Artificial neural network analysis of bone quality DXA parameters response to teriparatide in fractured osteoporotic patients
por: Messina, Carmelo, et al.
Publicado: (2020)

The effect of fracture recency on observed 5-year fracture probability: A study based on the FRISBEE cohort
por: Iconaru, L., et al.
Publicado: (2023)

PSAT182 Dilemmas in the Diagnosis and Management of Osteoporosis in a patient with Alkaptonuria: Successful Treatment with Teriparatide
por: Ebrahim, Ismail, et al.
Publicado: (2022)

Evaluation of the serum metabolome of patients with alkaptonuria before and after two years of treatment with nitisinone using LC‐QTOF‐MS
por: Davison, Andrew S., et al.
Publicado: (2019)

Heterotopic ossification vs. fracture healing: Extracellular vesicle cargo proteins shed new light on bone formation
por: Hrkac, Stela, et al.
Publicado: (2022)

Changes in BMD T-score from pre-to post-treatment with biosimilar teriparatide: A single-arm, multi-center study
por: Soroush, Mohsen G., et al.
Publicado: (2023)

Comparing nitisinone 2 mg and 10 mg in the treatment of alkaptonuria—An approach using statistical modelling
por: Ranganath, Lakshminarayan R., et al.
Publicado: (2021)

Radiological evolution of spinal disease in alkaptonuria and the effect of nitisinone
por: Imrich, Richard, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_de210bjqkvjl975tc84io4jqkm